StockMacro
Menu

ChronoScale

$7.95 -48% in 6 monthsMarket cap $1.3B

CHRN on XNAS, Manufacturing, ChronoScale Holdings Corporation, job postings

Measures activity, not value. Not investment advice.

Quarterly revenue rose 148% to $41.5M but the stock has fallen 52% in a month.

  • BadTwelve-month net loss of $81.6M on $96.4M revenue
  • Watch2 director or officer changes filed in the last 90 days

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 31 Aug 2026

ChronoScale Holdings Corp is providing cloud services to customers at third-party colocation centers located in Colorado, Minnesota and Utah, such as artificial intelligence and machine learning developers, seeking to develop their products. It design, develop, and market exoskeleton and complementary products that augment human strength, endurance, and mobility. Its Cloud Business provides graphics processing unit (GPU) computing solutions that enable customers to execute critical workloads related to artificial intelligence (AI), machine learning (ML), rendering, and other High Performance Computing (HPC) tasks at scale in a capacity-constrained market. It has one operating segment Cloud Business.

Industry
General industrial machinery & equipment, nec (Manufacturing)
Employees
88
Website
chronoscale.com
Listed
Nasdaq, US
Last results
15 Oct 2026
Next results
expected around 16 Feb 2027 (an estimate: a year ago it reported on 17 Feb 2026)
Revenue and net income per quarter. Quarter to 31 Aug 2026: revenue $41.5M, net loss $42.5M.
Quarter to 31 Dec 2021: revenue –, net income -$2.9MQuarter to 31 Mar 2022: revenue $2.6M, net income -$4.6MQuarter to 31 Mar 2022: revenue $2.6M, net income -$4.6MQuarter to 30 Jun 2022: revenue $3.5M, net income -$3.0MQuarter to 30 Jun 2022: revenue $3.5M, net income -$3.0MQuarter to 30 Sep 2022: revenue $3.3M, net income -$4.3MQuarter to 30 Sep 2022: revenue $3.3M, net income -$4.3MQuarter to 31 Dec 2022: revenue $3.6M, net income -$3.2MQuarter to 31 Dec 2022: revenue $3.6M, net income -$3.2MQuarter to 31 Mar 2023: revenue $4.1M, net income -$4.4MQuarter to 31 Mar 2023: revenue $4.1M, net income -$4.4MQuarter to 30 Jun 2023: revenue $4.7M, net income -$4.2MQuarter to 30 Jun 2023: revenue $4.7M, net income -$4.2MQuarter to 30 Sep 2023: revenue $4.6M, net income -$3.4MQuarter to 30 Sep 2023: revenue $4.6M, net income -$3.4MQuarter to 31 Dec 2023: revenue $4.8M, net income -$3.2MQuarter to 31 Dec 2023: revenue $4.8M, net income -$3.2MQuarter to 31 Mar 2024: revenue $3.8M, net income -$3.4MQuarter to 31 Mar 2024: revenue $3.8M, net income -$3.4MQuarter to 30 Jun 2024: revenue $5.0M, net income -$2.4MQuarter to 30 Jun 2024: revenue $5.0M, net income -$2.4MQuarter to 30 Sep 2024: revenue $4.1M, net income -$2.1MQuarter to 30 Sep 2024: revenue $4.1M, net income -$2.1MQuarter to 31 Dec 2024: revenue $5.1M, net income -$3.4MQuarter to 31 Dec 2024: revenue $5.1M, net income -$3.4MQuarter to 31 Mar 2025: revenue $3.4M, net income -$2.9MQuarter to 31 Mar 2025: revenue $3.4M, net income -$2.9MQuarter to 30 Jun 2025: revenue $2.1M, net income -$2.7MQuarter to 30 Jun 2025: revenue $2.1M, net income -$2.7MQuarter to 31 Aug 2025: revenue $16.7M, net income -$11.2MQuarter to 31 Aug 2025: revenue $16.7M, net income -$11.2MQuarter to 30 Sep 2025: revenue $4.2M, net income -$1.4MQuarter to 30 Sep 2025: revenue $4.2M, net income -$1.4MQuarter to 31 Dec 2025: revenue $3.1M, net income -$4.7MQuarter to 31 Dec 2025: revenue $3.1M, net income -$4.7MQuarter to 31 Mar 2026: revenue $2.1M, net income -$6.9MQuarter to 31 Mar 2026: revenue $2.1M, net income -$6.9MQuarter to 31 Aug 2026: revenue $41.5M, net income -$42.5MQuarter to 31 Aug 2026: revenue $41.5M, net income -$42.5M
31 Dec 2021RevenueNet incomeNet losstallest bar $42.5M31 Aug 2026
See the numbers
Quarter toRevenueNet income
31 Aug 2026$41.5M-$42.5M
31 Mar 2026$2.1M-$6.9M
31 Dec 2025$3.1M-$4.7M
30 Sep 2025$4.2M-$1.4M
31 Aug 2025$16.7M-$11.2M
30 Jun 2025$2.1M-$2.7M
31 Mar 2025$3.4M-$2.9M
31 Dec 2024$5.1M-$3.4M
30 Sep 2024$4.1M-$2.1M
30 Jun 2024$5.0M-$2.4M
31 Mar 2024$3.8M-$3.4M
31 Dec 2023$4.8M-$3.2M
30 Sep 2023$4.6M-$3.4M
30 Jun 2023$4.7M-$4.2M
31 Mar 2023$4.1M-$4.4M
31 Dec 2022$3.6M-$3.2M
30 Sep 2022$3.3M-$4.3M
30 Jun 2022$3.5M-$3.0M
31 Mar 2022$2.6M-$4.6M
31 Dec 2021–-$2.9M
Fundamentals, 12 months to 31 Aug 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $96.4M –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$81.6M –
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.57 –
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. -14.6% – 37.8%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -56.4% – 0.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -84.6% – 2.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -68.0% 2.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $15.2M $7K
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $10.7M –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$4.5M (net cash) –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.07 0.04
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.03
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 30.8
P/SPrice to sales: market cap divided by revenue of the last 12 months. 12.0 5.1
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 12.0 3.1
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 7.7 2.1

Latest = 12 months to 31 Aug 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
ChronoScaleCHRN (this company) $1.3Bloss12.0–-84.6%
Agility RoboticsAGLT $1.3Bloss–––
OusterOUST $1.7Bloss7.7+64%-20.4%
SymboticSYM $4.0B3201.5+21%0.5%
ESABESAB $4.6B29.71.5+11%5.1%
Serve RoboticsSERV $178.6Mloss18.0+411%–

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+11%

50 13F filers vs 45

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

1.2%

1.7M shares held by 13F filers (30 Sep 2026) of 145.6M outstanding (13 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

0.4%

598K shares sold short (30 Oct 2026) of 145.6M outstanding (13 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.4

598K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-6.8%

642K shares sold short in the report before, 598K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

79%

79% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 60%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+148%

$41.5M vs $16.7M (quarter ended 31 Aug 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

28

28 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

28×

28 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Revenue $41.5M, 2.5× a year earlier

Price $7.95 on 20 Nov 2026, -40% over 12 months (12-month range $7.95 to $29.63)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $1.2M in the last 12 months (the 12 months before: -$213K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).
Revenue per quarter. Revenue $41.5M in the latest quarter, +148% on a year earlier.
Capital spending per quarter. Capital spending $3.1M in the latest quarter.
Institutional holders (13F filers). 50 13F filers reported holding it in the latest 13F quarter, +4900% on a year earlier.
Lobbying spend. Lobbying spend: $0 published in the last 12 months, -100% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
15 Oct 2026Sharp changeQuarterly revenue change: quarterly revenue change, 41.5M vs usual 3.8M (2026-08-31); 2.5x the same period a year earlier
6 Oct 20268-K and other filingsDirector or officer change
2 Oct 20268-K and other filingsDirector or officer change
18 Aug 20268-K and other filingsDirector or officer change
30 Jun 20268-K and other filingsDirector or officer change
30 Jun 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Jun 20268-K and other filingsRestructuring costs announced
21 Mar 2026Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 4 filing(s) in 30 days, value_usd total 234K)
17 Feb 20268-K and other filingsDirector or officer change
17 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Nov 20258-K and other filingsDirector or officer change
7 Nov 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
17 Sep 20258-K and other filingsA major agreement ended
13 Dec 20248-K and other filingsDelisting notice or listing transfer
28 Aug 20248-K and other filingsRegistered new securities for sale (S-1)
29 Jul 20248-K and other filingsRegistered new securities for sale (S-1)
29 Sep 20238-K and other filingsDelisting notice or listing transfer
25 Apr 20238-K and other filingsDirector or officer change
25 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Feb 2023Lobbying filingnew lobbying registration (LNE GROUP)
9 Dec 20228-K and other filingsDirector or officer change
5 Dec 20228-K and other filingsCompleted an acquisition or asset sale
5 Dec 20228-K and other filingsDirector or officer change
28 Oct 20228-K and other filingsDirector or officer change
28 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
26 May 20228-K and other filingsDirector or officer change
10 Mar 20228-K and other filingsDirector or officer change
21 Jan 20228-K and other filingsDirector or officer change
28 Dec 20218-K and other filingsDirector or officer change
28 Dec 2021Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Mar 2022: -$53K published
Month from 1 Apr 2022: -$11K published
Month from 1 May 2022: -$28K published
Month from 1 Jun 2022: -$22K published
Month from 1 Jul 2022: -$19K published
Month from 1 Aug 2022: -$15K published
Month from 1 Sep 2022: -$24K published
Month from 1 Oct 2022: -$8K published
Month from 1 Nov 2022: -$9K published
Month from 1 Dec 2022: -$14K published
Month from 1 May 2023: -$71K published
Month from 1 Aug 2023: -$50K published
Month from 1 Mar 2024: $15K published
Month from 1 Nov 2025: -$213K published
Month from 1 Dec 2025: -$7K published
Month from 1 Jan 2026: -$12K published
Month from 1 Feb 2026: $1.2M published
Month from 1 Mar 2026: $31K published
H-1B/E-3 applications certified
Quarter from 1 Oct 2026: 3 published
Revenue per quarter
Quarter ended 31 Mar 2022: $2.6M, +34% on a year earlier; public on 29 Apr 2022
Quarter ended 30 Jun 2022: $3.5M, +57% on a year earlier; public on 29 Jul 2022
Quarter ended 30 Sep 2022: $3.3M, +9.2% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $3.6M; public on 29 Mar 2023
Quarter ended 31 Mar 2023: $4.1M, +61% on a year earlier; public on 28 Apr 2023
Quarter ended 30 Jun 2023: $4.7M, +36% on a year earlier; public on 28 Jul 2023
Quarter ended 30 Sep 2023: $4.6M, +38% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $4.8M, +36% on a year earlier; public on 5 Mar 2024
Quarter ended 31 Mar 2024: $3.8M, -8.9% on a year earlier; public on 30 Apr 2024
Quarter ended 30 Jun 2024: $5.0M, +5.3% on a year earlier; public on 30 Jul 2024
Quarter ended 30 Sep 2024: $4.1M, -10% on a year earlier; public on 29 Oct 2024
Quarter ended 31 Dec 2024: $5.1M, +5.0% on a year earlier; public on 4 Mar 2025
Quarter ended 31 Mar 2025: $3.4M, -10% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $2.1M, -58% on a year earlier; public on 29 Jul 2025
Quarter ended 31 Aug 2025: $16.7M; public on 15 Oct 2026
Quarter ended 30 Sep 2025: $4.2M, +2.4% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $3.1M, -38% on a year earlier; public on 24 Feb 2026
Quarter ended 31 Mar 2026: $2.1M, -37% on a year earlier; public on 29 Apr 2026
Quarter ended 31 Aug 2026: $41.5M, +148% on a year earlier; public on 15 Oct 2026
Capital spending per quarter
Quarter ended 31 Mar 2022: $0; public on 28 Apr 2023
Quarter ended 30 Sep 2022: $141K; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $53K; public on 29 Mar 2023
Quarter ended 31 Mar 2023: $42K; public on 28 Apr 2023
Quarter ended 30 Jun 2023: $55K; public on 28 Jul 2023
Quarter ended 30 Sep 2023: $17K, -88% on a year earlier; public on 27 Oct 2023
Quarter ended 31 Dec 2023: $43K, -19% on a year earlier; public on 5 Mar 2024
Quarter ended 31 Mar 2024: $8K, -81% on a year earlier; public on 30 Apr 2024
Quarter ended 30 Sep 2024: $8K, -53% on a year earlier; public on 29 Oct 2024
Quarter ended 31 Dec 2024: $21K, -51% on a year earlier; public on 4 Mar 2025
Quarter ended 31 Mar 2025: $10K, +25% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $40K; public on 29 Jul 2025
Quarter ended 30 Sep 2025: $12K, +50% on a year earlier; public on 29 Oct 2025
Quarter ended 31 Dec 2025: $126K, +500% on a year earlier; public on 24 Feb 2026
Quarter ended 31 Mar 2026: $0, -100% on a year earlier; public on 29 Apr 2026
Quarter ended 31 Aug 2026: $3.1M; public on 15 Oct 2026
Institutional holders (13F filers)
31 Mar 2026 report: 1; public on 15 May 2026
30 Jun 2026 report: 45; public on 14 Aug 2026
30 Sep 2026 report: 50; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Apr 2023: $10K published
Quarter from 1 Jul 2023: $10K published
Quarter from 1 Oct 2023: $70K published
Quarter from 1 Jan 2024: $40K published
Quarter from 1 Apr 2024: $20K published
Quarter from 1 Jul 2024: $20K published
Quarter from 1 Oct 2024: $20K published
Quarter from 1 Jan 2025: $10K published
Quarter from 1 Apr 2025: $10K published
Quarter from 1 Jul 2025: $10K published
Quarter from 1 Oct 2025: $10K published

What is unusual now

  • Made public in the last 90 days: it reported revenue of $41.5M for the quarter ended 31 Aug 2026, 2.5× the same quarter last year.
  • Quarterly revenue change: reported revenue of $41.5M for the quarter ended 31 Aug 2026, 2.5× the same quarter last year Public on 15 Oct 2026.
  • Insider net buying (open market): Insiders bought a net $1.2M in the last 12 months (the 12 months before: -$213K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 3 published in the last 12 months (none in the 12 months before).

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 51 insider trades

No trades in the last 90 days; the latest was filed 20 Mar 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 Mar 2026Jason C JonesChief Operating OfficerBuy1,308$11.85$15KForm 4
20 Mar 2026Jerome WongChief Financial OfficerBuy1,308$11.85$15KForm 4
20 Feb 2026Daniel Asher10% ownerBuy15,540$12.30$191KForm 4
19 Feb 2026Daniel Asher10% ownerBuy1,200$9.60$12KForm 4
17 Feb 2026Daniel Asher10% ownerBuy102,029$9.51$970KForm 4
7 Jan 2026Jason C JonesChief Operating OfficerSell1,320$9.25$12KForm 4
10 Dec 2025Jason C JonesChief Operating OfficerSell270$4.70$1KForm 4
10 Dec 2025Jerome WongChief Financial OfficerSell1,238$4.70$6KForm 4

50 institutions reported shares at the end of Q3 2026, 1% of the shares outstanding; 20 opened a position, 13 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Vident Advisory, LLC541K0.37%$10.7M+208K+62%
Hood River Capital Management LLC521K0.36%$10.3M+403K+342%
Dba Trading, LLC163K0.11%$3.2MNew+163K
Geode Capital Management, LLC120K0.08%$2.4M+63K+110%
UBS Group AG58K0.04%$1.1M+48K+513%
Vanguard Capital Management LLC33K0.02%$653K-4,501-12%
Sei Investments Co33K0.02%$644K+11K+51%
Morgan Stanley25K0.02%$493K-13K-34%
State Street Corp22K0.01%$431K+8,000+58%
Prime Capital Investment Advisors, LLC20K0.01%$395KNo change

Company events

All 78 company events

In 12 months: 6 major agreements, 5 director or officer changes, 1 restructuring. Results releases and routine reports are left out.

FiledWhat happenedSource
18 Nov 2026Entered two private placements: common stock at $8.00/share (about $153.0M expected) and up to $500M of Series C Preferred under a PEPASame filing: took on new debt, sold shares privately, changed its bylaws or fiscal year, shareholder vote results8-K
6 Oct 2026Director or officer change8-K
2 Oct 2026Director or officer changeSame filing: changed its bylaws or fiscal year8-K
16 Sep 2026Signed a major agreement8-K
18 Aug 2026Director or officer change8-K
30 Jun 2026Director or officer change8-K
26 Jun 2026Signed a major agreementSame filing: took on new debt8-K
4 Jun 2026Restructuring costs announced8-K

Reported lobbying spend: $10K in Q3 2025, $10K in Q2 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
10 Feb 2023NewLne Groupfor Ekso BionicsHealth and Human Services Dept Budget FY24BudgetFiling
31 Dec 2017EndedRed Maple Consulting, LLCfor Ekso Bionics, Inc.Research, development and acquisition of robotic exoskeletons.; FY18 Military Construction, Veterans Affairs Appropriations bill--robotic exoskeletons used for stroke and spinal cord injury rehabilitationVET, Budget, DefenseFiling
5 Nov 2015EndedCapitol Counsel LLCfor Ekso Bionics, Inc.Monitoring various health care issues relating to the Veteran's Administration and the Department of Defense.Health issuesFiling
19 Oct 2015NewRed Maple Consulting, LLCfor Ekso Bionics, Inc.Research, development and acquisition of robotic exoskeletons.VETFiling
1 Jun 2012NewCapitol Counsel LLCfor Ekso Bionics, Inc.Monioring various health care issues relating to the Veteran's Administration.Health issuesFiling

The 5 newest of 121 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 15 Oct 2026Financials change

    reported revenue of $41.5M for the quarter ended 31 Aug 2026, 2.5× the same quarter last year.

    Same quarter last year: $16.7M; its normal quarter is $3.8M.

    See the evidence
    This period
    $41.5M (the quarter ended 31 Aug 2026)
    Normal quarter (median of 8 earlier)
    $3.8M
    Typical spread (median absolute deviation)
    $975K
    How far from its usual level
    +26.1
    Same quarter last year
    $16.7M
    History used
    3,805 days
    2024-09-30: $4.1M2024-12-31: $5.1M2025-03-31: $3.4M2025-06-30: $2.1M2025-08-31: $16.7M2025-09-30: $4.2M2025-12-31: $3.1M2026-03-31: $2.1M2026-08-31: $41.5M
    the quarter ended 31 Aug 20268 earlier quartersnormal: $3.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  2. 6 Oct 2026Filings record

    Director or officer change

  3. 2 Oct 2026Filings record

    Director or officer change

  4. 18 Aug 2026Filings record

    Director or officer change

  5. 30 Jun 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 30 Jun 2026Filings record

    Director or officer change

  7. 4 Jun 2026Filings record

    Restructuring costs announced

  8. 21 Mar 2026Insiders change

    had 3 insiders buy $234K of its shares on the open market within 30 days (4 filings).

    Who bought: Asher Daniel, Wong Jerome, Jones Jason C.

    See the evidence (4 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    4
    Total bought
    $234K
    Window
    19 Feb 2026 to 21 Mar 2026

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  9. 21 Mar 2026Insiders record

    Jones Jason C (Chief Operating Officer) bought 1,308 shares of EKSO ($15,500) (dated 20 Mar 2026)

  10. 21 Mar 2026Insiders record

    Wong Jerome (Chief Financial Officer) bought 1,308 shares of EKSO ($15,500) (dated 20 Mar 2026)

  11. 21 Feb 2026Insiders record

    ASHER DANIEL (ten percent owner) bought 15,540 shares of EKSO ($191,142) (dated 20 Feb 2026)

  12. 20 Feb 2026Insiders record

    ASHER DANIEL (ten percent owner) bought 1,200 shares of EKSO ($11,520) (dated 19 Feb 2026)

  13. 18 Feb 2026Insiders record

    ASHER DANIEL (ten percent owner) bought 102,029 shares of EKSO ($969,939) (dated 17 Feb 2026)

  14. 17 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  15. 17 Feb 2026Filings record

    Director or officer change

  16. 7 Nov 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 7 Nov 2025Filings record

    Director or officer change

  18. 17 Sep 2025Filings record

    A major agreement ended

  19. 13 Dec 2024Filings record

    Delisting notice or listing transfer

  20. 28 Aug 2024Filings record

    Registered new securities for sale (S-1)

  21. 29 Jul 2024Filings record

    Registered new securities for sale (S-1)

  22. 15 Mar 2024Insiders record

    Lathan Corinna (director) bought 13,733 shares of EKSO ($15,476) (dated 14 Mar 2024)

  23. 29 Sep 2023Filings record

    Delisting notice or listing transfer

  24. 25 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 25 Apr 2023Filings record

    Director or officer change

  26. 22 Feb 2023Lobbying record

    EKSO BIONICS: new lobbying registration (LNE GROUP) (dated 10 Feb 2023)

  27. 9 Dec 2022Filings record

    Director or officer change (dated 8 Dec 2022)

  28. 5 Dec 2022Filings record

    Director or officer change

  29. 5 Dec 2022Filings record

    Completed an acquisition or asset sale

  30. 28 Oct 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  31. 28 Oct 2022Filings record

    Director or officer change

  32. 26 May 2022Filings record

    Director or officer change

  33. 10 Mar 2022Filings record

    Director or officer change

  34. 21 Jan 2022Filings record

    Director or officer change

  35. 28 Dec 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 28 Dec 2021Filings record

    Director or officer change

  37. 21 Jul 2021Filings record

    Changed its auditor

  38. 16 Apr 2021Filings record

    Director or officer change

  39. 5 Mar 2021Filings record

    Director or officer change

  40. 12 Feb 2021Filings record

    Private placement of securities (Form D)

Showing the newest 40 of 79 entries; narrow the window or the kind of data to see older ones.

Not listed: 198 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001549084
Ticker
CHRN
Domain
chronoscale.com
Employer name
chronoscale (1 unverified)
Hq location
CA|MENLO PARK|94025 (1 unverified)
Lobbying client
ekso bionics
Name
ChronoScale Corp, ChronoScale Holdings Corporation, ChronoScale Intermediate LLC, Ekso Bionics (Asia) Pte. Ltd and 4 more
  • DOL H-1B labor condition applications and PERM certifications5 data points14 Sep 2026 to 14 Sep 2026
  • Federal lobbying disclosures (LDA)5 records, 104 data points1 Jun 2012 to 30 Sep 2026
  • SEC Form 13F institutional holdings27 data points31 Mar 2026 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)210 records26 Feb 2016 to 18 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1104 data points31 Dec 2011 to 13 Oct 2026
  • SEC Form 4 insider transactions51 records, 164 data points15 Nov 2016 to 20 Mar 2026
  • FINRA short interest (twice monthly)36 data points15 May 2026 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)280 data points5 May 2026 to 20 Nov 2026